Last reviewed · How we verify
NCT05073562
A Study on the Effectiveness of IFA Supplementation, Deworming, and Nutrition Education in Addressing Anemia Among Adolescent Girls in Two Counties in Liberia
NA trial testing Iron and folic acid (IFA) supplementation in Nutritional Anemia. Withdrawn.
1 December 2021
Quick facts
| Lead sponsor | Boston Children's Hospital |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Start date | 1 October 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
Drugs / interventions tested
- Iron and folic acid (IFA) supplementation
- Targeted nutrition education
- Mebendazole Pill — full drug profile →
- Standard nutrition services
Conditions studied
- Nutritional Anemia — all drugs for Nutritional Anemia →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
- Iron Deficiency Anemia Treatment — all drugs for Iron Deficiency Anemia Treatment →
- Folic Acid Deficiency Anemia, Dietary — all drugs for Folic Acid Deficiency Anemia, Dietary →
Sponsor
Boston Children's Hospital
Who can join
Adults 10 to 19, female only, with Nutritional Anemia or Nutritional Deficiency. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change in participants' hemoglobin level from enrollment to completion of the study
Time frame: Baseline and Week 12
Point of care hemoglobin testing will be conducted at enrollment and at the conclusion of the study.
Sponsor's own description
The purpose of this study is to evaluate the feasibility and effectiveness of weekly iron and folic acid (IFA) supplementation and one-time deworming treatment at the community level in improving hemoglobin levels among adolescent girls in Liberia, West Africa, and to assess the feasibility and effectiveness of a targeted nutrition education program in improving nutrition knowledge, attitudes, and practices in the same population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05073562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Boston Children's Hospital trials
Trials by the same sponsor.
- NCT06804382 — Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP · NA · not yet recruiting
- NCT05113394 — Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy · Phase 2 · withdrawn
- NCT06434220 — Effect of Predictive Model on ED Physician Assessments of Patient Disposition · NA · not yet recruiting
- NCT07476430 — Readiness Outcomes Affecting Return to Sport 3.0 · NA · not yet recruiting
- NCT06706336 — Radon Asthma Intervention Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05073562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Children's Hospital
- Last refreshed: 13 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05073562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing